302 related articles for article (PubMed ID: 29566753)
1. A physician targeted intervention improves prescribing in chronic heart failure in general medical units.
Chua CC; Hutchinson A; Tacey M; Parikh S; Lim WK; Aboltins C
BMC Health Serv Res; 2018 Mar; 18(1):206. PubMed ID: 29566753
[TBL] [Abstract][Full Text] [Related]
2. Effect of Prescribing Patterns of Renin-Angiotensin System Blockers and Beta-Blockers on Prognosis of Heart Failure.
Kim HJ; Jo SH; Lee MH; Seo WW; Choi JO; Ryu KH
Adv Ther; 2020 Sep; 37(9):3839-3849. PubMed ID: 32676928
[TBL] [Abstract][Full Text] [Related]
3. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
[TBL] [Abstract][Full Text] [Related]
5. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
[TBL] [Abstract][Full Text] [Related]
6. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A
Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781
[TBL] [Abstract][Full Text] [Related]
7. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
[TBL] [Abstract][Full Text] [Related]
8. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
[TBL] [Abstract][Full Text] [Related]
9. Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF.
Beusekamp JC; Tromp J; van der Wal HH; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Rossignol P; Zannad F; Voors AA; van der Meer P
Eur J Heart Fail; 2018 May; 20(5):923-930. PubMed ID: 29327797
[TBL] [Abstract][Full Text] [Related]
10. Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases.
Kruik-Kollöffel WJ; van der Palen J; Doggen CJM; van Maaren MC; Kruik HJ; Heintjes EM; Movig KLL; Linssen GCM
PLoS One; 2020; 15(12):e0244231. PubMed ID: 33351823
[TBL] [Abstract][Full Text] [Related]
11. Prescribing Data in General Practice Demonstration (PDGPD) project--a cluster randomised controlled trial of a quality improvement intervention to achieve better prescribing for chronic heart failure and hypertension.
Williamson M; Cardona-Morrell M; Elliott JD; Reeve JF; Stocks NP; Emery J; Mackson JM; Gunn JM
BMC Health Serv Res; 2012 Aug; 12():273. PubMed ID: 22913571
[TBL] [Abstract][Full Text] [Related]
12. Establishing Baseline Metrics of Heart Failure Medication Use in Children: A Collaborative Effort from the ACTION Network.
Stidham J; Feingold B; Almond CS; Burstein DS; Krack P; Price JF; Schumacher KR; Spinner JA; Rosenthal DN; Lorts A; Godown J
Pediatr Cardiol; 2021 Feb; 42(2):315-323. PubMed ID: 33044586
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
Johnson D; Jin Y; Quan H; Cujec B
J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
[TBL] [Abstract][Full Text] [Related]
14. Analysis Treatment Guideline versus Clinical Practice Protocol in Patients Hospitalized due to Heart Failure.
Corrêa Ada G; Makdisse M; Katz M; Santana TC; Yokota PK; Galvão Tde F; Bacal F
Arq Bras Cardiol; 2016 Mar; 106(3):210-7. PubMed ID: 26815461
[TBL] [Abstract][Full Text] [Related]
15. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
Fröhlich H; Nelges C; Täger T; Schwenger V; Cebola R; Schnorbach J; Goode KM; Kazmi S; Katus HA; Cleland JG; Clark AL; Frankenstein L
Am Heart J; 2016 Aug; 178():28-36. PubMed ID: 27502849
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?
Richardson A; Tolley E; Hartmann J; Reedus J; Bowlin B; Finch C; Sands CW; Self T
Respir Med; 2016 Oct; 119():135-140. PubMed ID: 27692135
[TBL] [Abstract][Full Text] [Related]
17. Outpatient management of heart failure in the United States, 2006-2008.
Mosalpuria K; Agarwal SK; Yaemsiri S; Pierre-Louis B; Saba S; Alvarez R; Russell SD
Tex Heart Inst J; 2014 Jun; 41(3):253-61. PubMed ID: 24955039
[TBL] [Abstract][Full Text] [Related]
18. Dual renin-angiotensin-aldosterone blockade: Implementation of published research and Dear Doctor letters in ambulatory care: A retrospective observational study using prescription data.
Angelow A; Ploner T; Grimmsmann T; Walker J; Chenot JF
Pharmacoepidemiol Drug Saf; 2020 May; 29(5):530-537. PubMed ID: 32162407
[TBL] [Abstract][Full Text] [Related]
19. Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients.
Wawruch M; Slezakova V; Murin J; Luha J; Bozik M; Leitmann T; Kuzelova M; Shah R
Aging Clin Exp Res; 2014 Jun; 26(3):307-14. PubMed ID: 24781831
[TBL] [Abstract][Full Text] [Related]
20. Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure.
Watz R; Ekstrand AB; Engelbrektson V; Beermann B
Eur J Clin Pharmacol; 2005 May; 61(3):209-14. PubMed ID: 15761755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
